Recruiting

GLP-1 RA & CGM

Sponsor:

Montefiore Medical Center

Code:

NCT07948928

Conditions

Diabetes Mellitus, Type 2

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Our Practice Advisory (OPA) alert

Study Details

Brief summary:

This randomized quality improvement study will evaluate whether pop-up alerts in the electronic health record (EHR) increase prescribing of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications and continuous glucose monitors (CGMs) for eligible patients with diabetes. The study will be conducted at nine Montefiore Medical Group primary care sites. Primary care providers will be randomly assigned to either receive the alerts or not receive them. The alerts will remind providers that a patient is eligible for a GLP-1 RA, a CGM, or both, and will help them choose the option covered by the patient's insurance. Providers in both groups will use their own clinical judgment in deciding whether to prescribe. The study will use information already recorded in patients' medical records.

Conditions

Diabetes Mellitus, Type 2

Diabetes Mellitus

Study ID

NCT07948928

Start date

Nov, 2026

Status verified date

Nov, 2026

Completion date

Mar, 2027

Anticipated

Primary completion date

Mar, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Meet Klompas definition of diabetes
  • Has at least one primary care visit, in-person or telehealth, during the study period
  • Is covered by Medicare or Medicaid

Additional inclusion criteria for the GLP-1 portion of the OPA alert:

  • GLP-1 component: HbA1c ≥ 9 on most recent lab test in the past 12 months and a BMI ≥ 25) OR BMI ≥ 30, and no GLP-1 prescription in the past 12 months

Additional inclusion criteria for the CGM portion of the OPA alert:

  • CGM component: Insulin prescription in the past 12 months and no CGM prescription in the past 12 months

Exclusion Criteria:

  • Patients seen by residents during their first visit

Study Design

Enrollment

2989 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Our Practice Advisory (OPA) Alert

Education will be provided on the use of the alerts to PCPs in the intervention group. Providers will continue using clinical judgment for the appropriateness of the GLP-1 medication or CGM device for their patients.

no intervention: Usual Care (UC)

Providers continue usual care, with no alert. Providers will use clinical judgment for the appropriateness of the GLP-1 medication or CGM device for their patients.

Interventions

Our Practice Advisory (OPA) alert

Electronic Health Record (EHR) Our Practice Advisory, a pop-up electronic notification for clinical staff available at the time of a clinical encounter in the electronic medical record, recommending the insurance-preferred GLP-1 and/or a CGM, plus education for providers on using the alerts

Primary outcome measure

  • Percentage of Eligible Patients Newly Prescribed an Insurance-preferred GLP-1 medication [ Time Frame: At the first qualifying primary care visit during the study period, up to 3 months ]
  • Percentage of Eligible Patients Newly Prescribed a CGM [ Time Frame: At the first qualifying primary care visit during the study period, up to 3 months ]

Central Contacts and Locations

Central contacts

Locations

Montefiore Medical Center

Recruiting

The Bronx, New York, United States, 10467

Contacts

Shivani Agarwal, MD, MPH

844-556-6683shagarwa@montefiore.org

More Information

Sponsor

Montefiore Medical Center

Last update posted

Nov 19, 2026

Last verified

Nov, 2026

Keywords

  • Clinical Decision Support
  • GLP-1 Receptor Agonist
  • Continuous Glucose Monitoring (CGM)
  • Rapid-cycle Randomized Quality Improvement (QI)

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Montefiore Medical Center on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.